The Cooper Companies, Inc. (NASDAQ:COO) Shares Acquired by Greenleaf Trust

Greenleaf Trust lifted its position in The Cooper Companies, Inc. (NASDAQ:COO) by 5.0% during the fourth quarter, HoldingsChannel.com reports. The fund owned 2,915 shares of the medical device company’s stock after acquiring an additional 139 shares during the period. Greenleaf Trust’s holdings in Cooper Companies were worth $268,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Northwestern Mutual Wealth Management Co. boosted its stake in Cooper Companies by 23.4% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,868 shares of the medical device company’s stock worth $163,000 after purchasing an additional 354 shares during the last quarter. B. Riley Wealth Advisors Inc. boosted its position in Cooper Companies by 113.1% during the second quarter. B. Riley Wealth Advisors Inc. now owns 2,529 shares of the medical device company’s stock worth $221,000 after acquiring an additional 1,342 shares during the last quarter. Cetera Investment Advisers grew its stake in Cooper Companies by 6.3% during the 2nd quarter. Cetera Investment Advisers now owns 22,244 shares of the medical device company’s stock valued at $1,942,000 after acquiring an additional 1,309 shares in the last quarter. Park Avenue Securities LLC acquired a new stake in Cooper Companies in the 3rd quarter valued at about $850,000. Finally, Czech National Bank boosted its holdings in shares of Cooper Companies by 7.1% during the 3rd quarter. Czech National Bank now owns 40,562 shares of the medical device company’s stock worth $4,476,000 after purchasing an additional 2,688 shares during the last quarter. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities research analysts recently commented on the company. StockNews.com cut Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Wells Fargo & Company raised their target price on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, December 6th. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. Citigroup cut their price objective on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research report on Friday, December 6th. Finally, Morgan Stanley decreased their target price on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a report on Friday, December 6th. Four research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $117.00.

Cooper Companies Stock Performance

Shares of COO stock opened at $96.67 on Thursday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The firm has a market cap of $19.29 billion, a P/E ratio of 49.57, a P/E/G ratio of 2.45 and a beta of 1.00. The firm’s 50 day moving average price is $95.37 and its 200-day moving average price is $99.75. The Cooper Companies, Inc. has a one year low of $84.76 and a one year high of $112.38.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, topping analysts’ consensus estimates of $1.00 by $0.04. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1.03 billion. During the same period in the prior year, the firm earned $0.87 earnings per share. The firm’s revenue was up 9.8% compared to the same quarter last year. As a group, equities research analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.